Jing Du1, Qiu Chen, Hiroshi Takemori, Haiyan Xu. 1. Brown Medical School, Department of Medicine, Hallett Center for Diabetes and Endocrinology, Providence, RI, USA.
Abstract
OBJECTIVE: Determine the biological function of SIK2 in 3T3-L1 adipocytes. METHODS AND PROCEDURES: 3T3-L1 adipocytes were treated with serum-free, serum/glucose-free, or complete Dulbecco's Modified Eagle's Medium (DMEM) for 15 min, or 10 microg/ml oligomycin in serum-free DMEM for 15 min, or different doses of 5-amino-4-imidazolecarboxamide (AICAR) for different periods of time in serum-free DMEM. After treatment, SIK2 kinase activity was measured by examining phosphorylation of a peptide substrate. SIK2 was overexpressed and knocked down in 3T3-L1 CAR adipocytes using adenovirus-mediated gene transfer for the assessment of lipogenic gene expression and triglyceride content. Electroporation was used to transiently transfect 3T3-L1 adipocytes with fatty acid synthase (FAS) promoter-driven luciferase construct to evaluate the effect of SIK2 on FAS transcription. RESULTS: In 3T3-L1 adipocytes, SIK2 can be activated by nutrient deprivation, inhibition of ATP synthesis, and treatment of AICAR. Overexpression of SIK2 repressed the expression of lipogenic genes, including FAS, acetyl CoA carboxylase 2 (ACC2), and stearoyl CoA desaturase 1 (SCD1), and reduced triglyceride content. Reduction of endogenous SIK2 expression through RNA interference increased the expression of FAS, ACC2, and SCD1. This effect is independent of adenosine monophosphate-activated protein kinase (AMPK) since neither phosphorylation state nor protein level of AMPKalpha1 and AMPKalpha2 was affected by SIK2 overexpression. SIK2 inhibits the expression of FAS-promoter driven luciferase reporter gene, and this effect can be reversed by overexpression of constitutively active sterol regulatory element binding protein-1 (SREBP-1). Furthermore, SIK2 also reduces the nuclear translocation of endogenous SREBP-1. DISCUSSION: Our results support a role for SIK2 in adipocyte energy metabolism. SIK2 may function similarly to AMPK for turning off lipogenesis in low-energy state.
OBJECTIVE: Determine the biological function of SIK2 in 3T3-L1 adipocytes. METHODS AND PROCEDURES: 3T3-L1 adipocytes were treated with serum-free, serum/glucose-free, or complete Dulbecco's Modified Eagle's Medium (DMEM) for 15 min, or 10 microg/ml oligomycin in serum-free DMEM for 15 min, or different doses of 5-amino-4-imidazolecarboxamide (AICAR) for different periods of time in serum-free DMEM. After treatment, SIK2 kinase activity was measured by examining phosphorylation of a peptide substrate. SIK2 was overexpressed and knocked down in 3T3-L1 CAR adipocytes using adenovirus-mediated gene transfer for the assessment of lipogenic gene expression and triglyceride content. Electroporation was used to transiently transfect 3T3-L1 adipocytes with fatty acid synthase (FAS) promoter-driven luciferase construct to evaluate the effect of SIK2 on FAS transcription. RESULTS: In 3T3-L1 adipocytes, SIK2 can be activated by nutrient deprivation, inhibition of ATP synthesis, and treatment of AICAR. Overexpression of SIK2 repressed the expression of lipogenic genes, including FAS, acetyl CoA carboxylase 2 (ACC2), and stearoyl CoA desaturase 1 (SCD1), and reduced triglyceride content. Reduction of endogenous SIK2 expression through RNA interference increased the expression of FAS, ACC2, and SCD1. This effect is independent of adenosine monophosphate-activated protein kinase (AMPK) since neither phosphorylation state nor protein level of AMPKalpha1 and AMPKalpha2 was affected by SIK2 overexpression. SIK2 inhibits the expression of FAS-promoter driven luciferase reporter gene, and this effect can be reversed by overexpression of constitutively active sterol regulatory element binding protein-1 (SREBP-1). Furthermore, SIK2 also reduces the nuclear translocation of endogenous SREBP-1. DISCUSSION: Our results support a role for SIK2 in adipocyte energy metabolism. SIK2 may function similarly to AMPK for turning off lipogenesis in low-energy state.
Authors: Emma Henriksson; Johanna Säll; Amélie Gormand; Sebastian Wasserstrom; Nicholas A Morrice; Andreas M Fritzen; Marc Foretz; David G Campbell; Kei Sakamoto; Mikael Ekelund; Eva Degerman; Karin G Stenkula; Olga Göransson Journal: J Cell Sci Date: 2015-02-01 Impact factor: 5.285
Authors: Emma Henriksson; Helena A Jones; Kashyap Patel; Mark Peggie; Nicholas Morrice; Kei Sakamoto; Olga Göransson Journal: Biochem J Date: 2012-06-15 Impact factor: 3.857
Authors: Johanna Säll; Annie M L Pettersson; Christel Björk; Emma Henriksson; Sebastian Wasserstrom; Wilhelm Linder; Yuedan Zhou; Ola Hansson; Daniel P Andersson; Mikael Ekelund; Eva Degerman; Karin G Stenkula; Jurga Laurencikiene; Olga Göransson Journal: Diabetologia Date: 2016-11-02 Impact factor: 10.122